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MiRNA profiling of the murine hematopoietic system<p>The first report of systematic miRNA profiling in cells of the hematopoietic system suggests that, in addition to regulating commitment to particular c llular lineages, miRNAs might have a g neral role in cell differentiation and cell identity.</p>
Abstract
Background: MicroRNAs (miRNAs) are a class of recently discovered noncoding RNA genes that
post-transcriptionally regulate gene expression. It is becoming clear that miRNAs play an important
role in the regulation of gene expression during development. However, in mammals, expression
data are principally based on whole tissue analysis and are still very incomplete.
Results: We used oligonucleotide arrays to analyze miRNA expression in the murine
hematopoietic system. Complementary oligonucleotides capable of hybridizing to 181 miRNAs
were immobilized on a membrane and probed with radiolabeled RNA derived from low molecular
weight fractions of total RNA from several different hematopoietic and neuronal cells. This method
allowed us to analyze cell type-specific patterns of miRNA expression and to identify miRNAs that
might be important for cell lineage specification and/or cell effector functions.
Conclusion: This is the first report of systematic miRNA gene profiling in cells of the
hematopoietic system. As expected, miRNA expression patterns were very different between
hematopoietic and non-hematopoietic cells, with further subtle differences observed within the
hematopoietic group. Interestingly, the most pronounced similarities were observed among fully
differentiated effector cells (Th1 and Th2 lymphocytes and mast cells) and precursors at
comparable stages of differentiation (double negative thymocytes and pro-B cells), suggesting that
in addition to regulating the process of commitment to particular cellular lineages, miRNAs might
have an important general role in the mechanism of cell differentiation and maintenance of cell
identity.
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MicroRNAs (miRNAs) represent a recently discovered class
of small, noncoding RNAs, found in organisms ranging from
nematodes to plants to humans. Many individual miRNAs are
conserved across widely diverse phyla, indicating their phys-
iological importance. The primary transcript (pri-miRNA) is
generally transcribed by RNA polymerase II; it contains a typ-
ical stem-loop structure that is processed by a nuclear enzyme
complex including Drosha and Pasha, and releases a 60- to
110-nucleotide pre-miRNA hairpin precursor [1]. The pre-
miRNA is further processed by Dicer to yield the 19- to 22-
nucleotide mature miRNA product, which is then incorpo-
rated into the RNA-induced silencing complex (RISC) [2-4].
RISC-bound miRNAs direct the cleavage and/or translational
repression of messenger RNAs, thus providing post-tran-
scriptional control of gene expression.
Like many transcription factors, miRNAs are important
determinants of cellular fate specification. One of the most
prominent and genetically best-studied examples is given by
miRNAs involved in neuronal fate determination in
Caenorhabditis elegans, where a cascade of several miRNAs
and transcription factors regulate each other's activity to
induce a different spectrum of putative chemoreceptors in the
two main taste receptor neurons in C. elegans [5]. Further-
more, many miRNA genes are located at fragile sites, minimal
loss of heterozygosity regions, minimal regions of amplifica-
tion, or common breakpoints in human cancers, suggesting
that miRNAs might play an important role in the pathogene-
sis of human cancer [6,7].
Hundreds of miRNAs have been identified in plants and ani-
mals, either through computational searches, RT-PCR-medi-
ated cloning, or both. More than 200 human and rodent
miRNAs have been reported and tabulated in the miRNA
Registry [8], accounting for an estimated 1-2% of expressed
human genes. Recent evidence suggests that the actual
number of miRNAs is likely to be even larger [9,10]. MiRNAs
have been implicated in biological processes ranging from cell
proliferation and cell death during development to stress
resistance, fat metabolism, insulin secretion and hematopoi-
esis [11]. However, for the most part, the regulation and func-
tion of most mammalian miRNAs are unknown. The bulk of
the existing data on miRNA expression in mammalian cells
has been derived from studies on whole tissues, which con-
tain many heterogeneous cell types, or on transformed or
established cell lines that may have diverged significantly
from the primary cell types that they are assumed to repre-
sent [7,12-15]. To understand the role of miRNAs in mamma-
lian development and differentiation, an important starting
point is a systematic compilation of miRNAs expressed in
individual cell types, especially those derived by differentia-
tion from a common precursor.
The cells of the immune system originate from hematopoietic
stem cells in the bone marrow, where many of them also
mature. The hematopoietic stem cells give rise to both mye-
loid and lymphoid progenitors. The myeloid progenitor is the
precursor of granulocytes, macrophages, dendritic cells, and
mast cells of the innate immune system. Mast cells, whose
blood-borne precursors are not well defined, terminate their
differentiation in the body tissues, where they are widely dis-
tributed and where they orchestrate allergic responses and
play a part in protecting mucosal surfaces against pathogens
[16]. The common lymphoid progenitor gives rise to B and T
lymphocytes and to natural killer cells. B lymphocytes differ-
entiate in the bone marrow and T lymphocytes in the thymus;
the stages of B and T cell development are defined by sequen-
tial rearrangement and expression of heavy- and light-chain
immunoglobulin genes and TCR α and β chains, respectively.
Mature B and T lymphocytes that have emigrated to the
peripheral lymphoid organs, including the spleen and lymph
nodes, but have not yet encountered their specific antigen are
called 'naïve'. In the event of an infection, T lymphocytes that
recognize the infectious agent are arrested in the lymphoid
organs, where they proliferate and differentiate further into
effector cells capable of combating the infection.
Because of the wealth of information available about the tran-
scriptional and cellular networks involved in hematopoietic
differentiation, the hematopoietic system is ideal for studying
cell lineage specification. Many of the common progenitors of
hematopoietic cells can be obtained as primary cells from
humans and mice, and expanded and differentiated in vitro.
Here we have performed a detailed analysis of miRNA expres-
sion in diverse hematopoietic cell types from the mouse,
using a high-throughput system that allows analysis of many
samples with minimal manipulation of the samples them-
selves. This has allowed us to identify miRNAs that are highly
expressed in the hematopoietic system. Our results are con-
sistent with a model of hematopoiesis in which transcrip-
tional regulators act in concert with differentially expressed
miRNAs to modulate the levels of mRNAs that control cell
differentiation pathways.
Results
Microarray design
To probe the expression of miRNAs in a variety of different
related and unrelated cell types, we chose to use miRNA
arrays in preference to time-consuming Northern analysis
that cannot be used efficiently with many different probes
and samples. In the past year, several microarray methods
have been developed [7,12,13,15,17-19]. Some of these groups
[7,12,13,15,17] used cDNA or cRNA generated from total cel-
lular RNA to apply to their microarrays. Other methods
[18,19] rely heavily on several enzymatic steps, such as RNA
ligation [18], or Klenow synthesis and exonuclease I degrada-
tion of ssDNA [19]. Instead, we chose a technique that does
not involve reverse transcription of RNA and relies on only
one enzymatic step ([20]; see Methods) thus reducing RNA
manipulation to a minimum. In designing the arrays, weGenome Biology 2005, 6:R71
http://genomebiology.com/2005/6/8/R71 Genome Biology 2005,     Volume 6, Issue 8, Article R71       Monticelli et al. R71.3
co
m
m
ent
review
s
repo
rts
refereed research
depo
sited research
interactio
ns
info
rm
atio
nexpanded the array dataset already developed by Krichevsky
et al. [20]. The new generation of arrays contains 181 gene-
specific oligonucleotide probes, corresponding to human, rat,
and mouse miRNAs as reported in the miRNA Registry [8].
Data from the arrays
Figure 1a shows a typical array experiment comparing
miRNA expression in bone marrow-derived mast cells
(BMMC) and a hematopoietic progenitor cell line (Pu.1-/-)
derived from mice lacking the Ets-family transcription factor
PU.1 [21]. This cell line differentiates efficiently into mast
cells when rescued with PU.1 under conditions where GATA2
expression is maintained; expression of PU.1 in the absence of
GATA2 results in commitment to the macrophage lineage
instead [22]. Visual comparison of three arrays performed
with each RNA sample shows the high reproducibility of the
arrays, and emphasizes the difference in miRNA expression
relative to hippocampal RNA (Figure 1a). This high degree of
reproducibility was maintained over a total of nine arrays,
each performed in triplicate using three independent RNA
samples (not shown). Statistical analysis confirmed the high
level of reproducibility (Figure 1b): when the standard devia-
Design and reproducibility of microarraysFigure 1
Design and reproducibility of microarrays. (a) Examples of microarrays: three membranes were used for each biological sample; arrays for Pu.1-/- cells, 
BMMC and hippocampus are shown. On the left, ethidium bromide staining of total RNA run on a denaturing gel for RNA quantification and quality 
control. (b) Plot of the standard deviation over replicates versus the mean of each replicate. The red line is a lowest fit to the distribution and the blue 
dotted line is twice the value of the red one. Points below the blue curve are considered good replicates; those above it are filtered out as too noisy. For 
this dataset, 86% of the spots were considered as good. BMMC, bone marrow-derived mast cells.
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licate, 86% of the spots were considered good (see legend to
Figure 1b for details). RNA loading for all arrays and North-
ern blot experiments was evaluated by ethidium bromide
staining of a denaturing acrylamide gel as shown in Figures 1a
and 2d.
The arrays were repeated using cells from several stages of
lymphocyte differentiation (Figure 2a). Among the cell types
compared were pro-B cells, which are in the process of rear-
ranging the heavy-chain immunoglobulin locus; mature
splenic B cells, which express IgM and IgD B cell receptors
and are competent to respond to antigen; double-negative
thymocytes (DN T), which are just beginning to rearrange
their T cell receptor chains and lack surface expression of the
CD4 and CD8 co-receptors; naïve CD4 T 'helper' cells, which
have exited the thymus, bear the CD4 co-receptor and a
mature T cell receptor, and are fully capable of recognizing
and responding to antigen; and Th1 and Th2 T helper subsets,
which are derived by differentiation from a common precur-
sor, the naïve CD4 T cell, and are characterized by selective
expression of the cytokines IFNγ and IL4, respectively. Figure
2a shows representative array data for pro-B cells, mature
splenic B cells, naïve T cells, and Th1 and Th2 clones. Note
that miR-150 is highly expressed in B cells purified from
mouse spleen, but not in pro-B cells isolated from bone mar-
row of Rag2-/- mice; it is also expressed in naïve T cells but is
down-regulated in the Th1 and Th2 T cell clones (Figure 2a,
arrow).
Validation of array data by Northern analysis
Before analyzing the entire dataset from the microarrays, we
validated the array results by Northern blot analysis. Single-
stranded DNA oligonucleotides complementary to over 40
different miRNAs were used as probes; they were chosen
because they were expressed in at least one cell type in the
hematopoietic lineages and/or were highly expressed in neu-
rons. Several of these Northern blots were already published
with the first description of the microarray methodology [20]
to confirm the array specificity. We performed several other
Northern blots that included hematopoietic cells and tissues.
These data are shown in Figures 2, 3 and 4, and summarized
in Tables  1 and 2. With minor exceptions as discussed below,
the results of Northern analysis were consistent with the
array data for most miRNAs, by simple visual inspection
(Table 2), and when the hybridization signal intensity was
quantified by phosphorimager (Figure 3 and Table 1). For
example, Northern analysis of miR-150 expression confirmed
its expression in spleen B but not pro-B cells (Figure 2b, lanes
6 and 7), and in naïve T cells but not the Th1 and Th2 clones,
D5 and D10 (Figure 2c, lanes 5-7). Figure 2b also shows that
miR-150 is expressed in thymocytes and splenic T cells (lanes
9 and 10), but not in ES cells, mouse embryo fibroblasts or
hippocampus (lanes 11-13). The lack of expression in RAG2-/
- spleen and thymus (lanes 5 and 8) confirms that expression
in these organs is confined to T and B lymphoid-lineage cells,
and that within these lineages, miR-150 expression is
restricted to cells that have developed beyond the DN T and
pro B stages of development. Figure 2c confirms that naïve T
cells show high level expression of miR-150 (lane 7) whereas
the precursor cell line Pu.1-/- and BMMC, which are of the
myeloid lineage, do not (lanes 1-4). Equivalent RNA loading
in all lanes was confirmed by ethidium bromide staining of a
denaturing acrylamide gel as shown in Figure 2d.
Strikingly, miR-150 expression in naïve T cells is rapidly
down-regulated upon TCR engagement, regardless of
whether T cells are stimulated under Th1 or Th2 conditions
(Figure 2c, lanes 8-12). The levels of expression of miR-150
were already reduced by ~50% after 12 h of stimulation with
plate-bound αCD3 and αCD28 (lane 8), and by >90% after 25
h (lanes 9 and 11), indicating a rapid and highly inducible
mechanism of down-regulation. Expression was barely
detectable after 49 h (lanes 10 and 12) and remained undetec-
table 3 days after stimulation (data not shown). Furthermore,
miRNA expression was extinguished in fully committed Th1
and Th2 T cell clones (lanes 5 and 6). Together, these results
suggest a role for miR-150 either in maintaining the undiffer-
entiated status of naïve T cells or in promoting early steps in
T cell differentiation.
Comparison of miR-150 expression by arrays and Northern blottingFigure 2 (see ollowing page)
Comparison of miR-150 expression by arrays and Northern blotting. (a) Array data show that miR-150 (arrows) is highly expressed in spleen B and naïve 
T cells, but not in pro-B cells or fully differentiated Th1 and Th2 clones. (b) Northern blot analysis for miR-150 in various lymphoid and non-lymphoid 
tissues and cell types. U6 RNA levels are shown as loading control. (c) Northern blots of different cell types unstimulated or stimulated for the indicated 
amounts of time with either PMA and ionomycin (BMMC) or anti-CD3 and anti-CD28 (Th1 and Th2 primary cells). Preliminary data obtained both in 
Northern blot and arrays showed no difference in miRNA expression between BMMC left untreated or treated with cyclosporin A (CsA) (not shown). 
(d) Ethidium bromide staining of gel of total RNA from samples used in Figure 2c, showing equivalent RNA amounts. BMMC, bone marrow-derived mast 
cells; MEF, mouse embryo fibroblast.Genome Biology 2005, 6:R71
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R71.6 Genome Biology 2005,     Volume 6, Issue 8, Article R71       Monticelli et al. http://genomebiology.com/2005/6/8/R71Figure 3 extends the concordance of the array data with the
Northern analysis to five additional miRNAs, emphasizing
the cell type-specific changes that take place during differen-
tiation. In the left panels of Figure 3, miRNA expression in
BMMC treated with cyclosporin A to prevent activation, or
stimulated with PMA and ionomycin for the indicated times,
is compared with expression in the Pu.1-/- 'precursor' cell
line, which gives rise to mast cells when reconstituted with
both PU.1 and GATA2 [22]. Three very different patterns are
observed, exemplified by: miR-146 and 142s, which are
expressed at essentially equivalent (low) levels in both the
Pu.1-/- precursor cells and the fully-differentiated BMMC;
miR-26a and 27a, which are expressed at low levels in the
Pu.1-/- precursor cells and at three- to fourfold higher levels
in fully differentiated BMMC; and miR-223, which is most
highly expressed in the Pu.1-/- precursor cells and is barely
detectable in the differentiated BMMC. The results of North-
ern analysis for these two cell types show an overall good con-
cordance with the values obtained from the arrays (Figures 2,
3 and 4 and Table 1).
The right panels of Figure 3 compare expression of the same
miRNAs in naïve T cells and fully-differentiated Th1 and Th2
cells (the D5 and D10 clones). Several expression patterns are
evident: miR-146 is highest in Th1 cells and low in naïve T
cells and Th2 cells; miRNAs 142s and 26a are expressed at
higher levels in the precursor naïve T cells; miR-27a is equiv-
alently expressed in both the precursor naïve T cells and the
differentiated Th1 and Th2 cells; and miR-223 is very poorly
expressed in all these T cell types. The relative expression of
these miRNAs in naïve versus differentiated T cells was con-
firmed in primary cultures of Th1 and Th2 cells (see Table 1).
There was full concordance of the Northern analysis with the
miRNA array data for miRNAs 146, 142s, 26a and 223 (Figure
3, Table 1); however, as discussed further below, the signal for
27a and a handful of other miRNAs expressed at low levels in
naïve T cells fell below the limit of detection on the
microarrays.
Table 1 summarizes the results from Northern analysis of the
miRNAs shown in Figures 2 and 3, as well as showing data for
two additional miRNAs, let7d (let7 family) and miR-222. The
miRNA expression pattern of D5 and D10 T cell clones was
comparable with that of differentiated primary Th1 and Th2
cells respectively, validating the use of D5 and D10 cells as
models for fully differentiated Th1 and Th2 cells. Like miR-
150, the expression of miR-142s, miR-26a and let7d showed a
rapid decline during differentiation of naïve T cells into Th1
or Th2 effectors. miR-27a was expressed at equivalent levels
in naïve and differentiated T cells. miR-146 showed a Th1-
skewed expression pattern: it's levels increased in Th1 cells
and decreased in Th2 cells relative to it's expression in naïve
T cells. We have not yet detected an miRNA with the converse
expression pattern of high expression in Th2 cells relative to
Th1. miR-222 was detectably expressed in BMMC, Pu.1-/-
precursor cells and fully differentiated Th1 cells, but it's
Microarrays and Northern blots correlate qualitatively and quantitativelyFigure 3
Microarrays and Northern blots correlate qualitatively and quantitatively. 
Northern blots for miRNA expression in mast cells (left panels), or T cells 
(right panels). BMMC were treated with cyclosporin A or PMA and 
ionomycin for the indicated amounts of time. Loading control is the same 
as Figure 2d. First row underneath the panels: ratio between the 
intensities of the Northern blot bands as assessed by phosphorimager and 
quantified by ImageQuant; all the samples are compared with Pu.1-/- cells 
except for miR-223, where each sample is compared with BMMC. Second 
row: these are also ratios between the intensities of the Northern blot 
bands, but the T cell samples are compared directly to each other. This 
allows a better direct comparison with the numbers on the third row, 
which are the ratios of BMMC versus Pu.1-/- cells (left panels) and D5 
versus D10 versus naïve T cells as obtained from the arrays (right panels). 
BMMC, bone marrow-derived mast cells; CsA, cyclosporin A; n.d., not 
detectable.
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nexpression was not detectable in the other cell types tested
(Table 1); in contrast, miR-16 was expressed in all cell types
analyzed, but it's expression was relatively variable both in
arrays and Northern blots, so quantification was not
attempted (data not shown). Some of our data confirm pub-
lished reports. For example, miR-223 is reported to be
expressed in myeloid cells [7,23]; miR-125 and 128 are highly
expressed in the brain [13,14]; and miR-16 is expressed in a
wide variety of tissues [7,14,23] (see also heat map of expres-
sion in Figure 5a).
Figure 4 shows Northern blot data for additional miRNAs.
Most of the data from Northern blots correlated at least qual-
itatively with the expression data from the arrays (Table 2;
Additional Northern blots showing miRNA expression in various tissues and cell typesFigure 4
Additional Northern blots showing miRNA expression in various tissues and cell types. Shown are Northern blot data for the indicated miRNAs in 
different unstimulated cell types. Asterisks indicate bands of the size of pre-miRNA (60-70 nucleotides), which were detected in Northern blot for only a 
subset of the miRNAs analyzed. There was a good correlation overall between Northern blot data and expression data from the arrays (see heat map in 
Figure 5 and Table 2), with some exceptions, as discussed in the text. BMMC, bone marrow-derived mast cells; DN T, double-negative thymocyte.
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R71.8 Genome Biology 2005,     Volume 6, Issue 8, Article R71       Monticelli et al. http://genomebiology.com/2005/6/8/R71also compare data in Figures 3 and 4 to the heat map in Figure
5). Some exceptions were noted. For some of the miRNAs
(miR-129, 151, 184, 185, 202, 212 and 351), we could not
obtain any hybridization signal on Northern blots, so we were
unable to compare Northern and array data. MiR-223 and
miR-206 showed poor correlation between the arrays and the
Northern blots: for miR-223, we detected a higher level of
expression in pro-B in the arrays compared with what we
detected on Northern blot, while for miR-206, the arrays
showed high expression in pro-B and DN T that was undetec-
table by Northern blot. In a few other cases, the hybridization
signal was lower in the arrays compared with Northern blots,
but the relative expression levels between different cell types
was similar. It is unclear at this point why the expression of
some miRNAs appears different depending on the method
used to detect them.
In a few cases, the probes used in Northern analysis hybrid-
ized to a cross-reacting band with a molecular weight higher
than the mature or pre-miRNA molecules. In these cases the
correlation between Northern blots (which use total RNA)
and arrays (which use the low-molecular weight RNA) was
only partial. Even though our system is designed to exclude
RNA molecules bigger than ~300 nucleotides, we effectively
obtained exclusion of molecules bigger than 60-80 nucle-
otides (as shown in [20]). Thus, the changes observed mainly
reflect changes in mature miRNA levels, as also shown by the
correlation with Northern blots. However, it remains possible
that a strong expression of cross-reacting RNA close to this
size might partially alter the array results; we observed such
bands for miR-186, miR-188 and miR-321. Of note, miR-321
has been removed from the microRNA Registry because it
was identified as a fragment of an Arg tRNA and not a
miRNA.
Despite differences in methods as well as in the number of
microRNAs analyzed, there is good agreement between our
results and those of others, with regard to specificity and sen-
sitivity, when array and Northern blot analyses are examined
for similar cell types [13,14]. Similar to the findings and dis-
cussion of Miska et al. [13], we do not expect our microarray
technique to provide sufficient specificity to distinguish relia-
bly between hybridizing sequences that have only one or few
nucleotide mismatches. Although hybridization signals from
several control probes containing three staggered nucleotide
mismatches were lower than that for the corresponding
miRNA probes (see also Material and methods), our method
cannot efficiently discriminate between close miRNA para-
logs. This limitation is alleviated somewhat by the fact that for
most miRNAs, the most closely related paralogs differ by five
mismatches or more [13]. The sensitivity of the arrays is sim-
ilar to that of Northern blots. Synthetic RNA oligonucleotides
'spiked' into cellular RNA samples prior to array hybridiza-
tion were detected at a 2-20 fmole range. Northern blot
allowed detection of as little as 1-10 fmole of synthetic oligo-
nucleotides (data not shown). In summary, therefore, we saw
substantial concordance between arrays and Northern blots,
allowing us to identify cell type-specific differences in miRNA
expression as well as differences between miRNAs expressed
by precursor cells and their differentiated progeny. This led
us to analyze the array data more extensively using computa-
tional methods.
Analysis of miRNA arrays
To identify patterns of miRNA expression among the cell
types tested, we arranged the array data for miRNAs that
were expressed at least three times over the background for at
least one of the samples in a heat map (Figure 5a). Brown to
white colors indicate increasing levels of miRNA expression
in arrays. This analysis revealed a cluster of miRNAs that
were preferentially expressed in the hippocampus compared
with hematopoietic cells, as indicated by the blue bar in the
left panel. MiRNAs expressed at higher levels in the hemat-
opoietic system are indicated by the purple bar in the right
panel.
Table 1
Northern blot quantification of miRNA
miR BMMC Pu.1-/- Naïve Th1 (49 h) D5 Th1 Th2 (49 h) D10 Th2
150 n.d. n.d. 39.4 3.5 n.d. 1.0 n.d.
146 1.7 1.0 2.8 3.7 6.8 1.3 1.0
142s 2.0 1.0 32.0 7.5 3.8 4.7 3.9
26a 3.1 1.0 13.8 1.4 3.0 1.2 2.5
27a 3.9 1.0 1.3 0.9 1.4 0.8 1.5
223 1.0 45.0 n.d. n.d. n.d. n.d. n.d.
Let7d 2.3 1.0 4.7 2.1 2.5 1.7 1.7
222 1.0 1.2 n.d. n.d. 1.1 n.d. n.d.
Northern blots for miRNA expressed in mast cells, precursor cells, and T cells at various stages of differentiation were quantified by 
phosphorimager. BMMC, bone marrow-derived mast cell; DN T, double-negative thymocyte; n.d., not detectable.Genome Biology 2005, 6:R71
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Correlation between arrays and Northern blot data
DNT Pro-B Spleen B BMMC Hippocampus
MiR 7 Arrays + ++ ++ +/- ++
Northerns + +++ ++ n.a. n.a.
MiR 24 Arrays +++ ++++ +++ ++ ++
Northerns ++ ++++ +++ n.a. n.a.
MiR 26a Arrays + + ++ +++ +++
Northerns + ++ +++ n.a. n.a.
MiR 29a Arrays + + ++ ++ +++
Northerns + + ++ nd +++
MiR 93 Arrays ++ ++ +/- ++ +/-
Northerns + ++ + n.a. n.a.
MiR 99a Arrays n.s.s. n.s.s. n.s.s. n.s.s. n.s.s.
Northerns +/- +/- - nd nd
MiR 101 Arrays ++ +++ + +++ ++
Northerns + + + nd ++
MiR-107 Arrays +++ +++ ++ ++ ++
Northerns + ++ + n.a. n.a.
MiR-127 Arrays +/- + + +/- +
Northerns - - - n.a. n.a.
MiR-142-3p Arrays +++ +++ ++++ +++ +
Northerns ++ +++ ++++ ++ n.a.
MiR-142-5p Arrays ++ + +++ ++ +
Northerns + ++ +++ + n.a.
MiR-144 Arrays n.s.s. n.s.s. n.s.s. n.s.s. n.s.s.
Northerns - - - n.a. n.a.
MiR-148 Arrays + + + + +/-
Northerns + + + n.a. n.a.
MiR-150 Arrays - + +++ + +/-
Northerns - - +++ n.a. -
MiR-181b Arrays + + + + ++
Northerns + + - n.a. +
MiR-191 Arrays +/- + + + +
Northerns + ++ ++ n.a. n.a.
MiR-199 Arrays + + + + +/-
Northerns - + - n.a. n.a.
MiR-206 Arrays ++ +++ + +/- +/-
Northerns - - - - n.a.
MiR-213 Arrays n.s.s. n.s.s. n.s.s. n.s.s. n.s.s.
Northerns - +/- - n.a. n.a.
MiR-223 Arrays + +++ + +/- +
Northerns +/- - + + n.a.
MiR-342 Arrays + + + + +
Northerns + +++ ++ n.a. n.a.
The table summarizes and compares the Northern blot data shown in Figure 4 and the array data shown in the heat map in Figure 5. Northern blot 
and array data were scored independently using an arbitrary scale from undetectable (-) to strongly detected (++++) to indicate relative signal 
intensity in each case. BMMC, bone marrow-derived mast cell; DN T, double-negative thymocyte; n.s.s., non statistically significant hybridization 
signal; n.a., not analyzed.Genome Biology 2005, 6:R71
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sion patterns correlate with hematopoietic cell differentia-
tion, we performed a hierarchical clustering of the normalized
array data for hematopoietic cell types (Figure 5b). The subset
of miRNAs detected in at least one hematopoietic cell sample
was used to compute the distance function from the Pearson
correlation between samples (Table 3). Standard hierarchical
clustering with average linkage was used, and bootstrap
resampling was employed to assess the robustness of the clus-
tering results. This analysis showed that fully differentiated
effector cells (Th1, Th2 and BMMC) are more closely related
to each other in their miRNA expression pattern than to their
respective precursor cells (DN T and Pu.1-/- precursor cells).
The miRNA expression patterns of pro-B and DN T, precur-
sor cells for the B and T lymphocyte lineages respectively,
were also very closely related. Although the detected miRNA
expression pattern of naïve T cells most closely resembled
that of splenic B cells (Table 3), naïve T cells were excluded
from the clustering analysis. This was because RNA isolated
from naïve T cells yielded much lower overall array hybridiza-
tion signals compared with RNA from the other cell types
examined, causing the signal for a handful of expressed miR-
NAs to fall below the limit of detection for the microarrays
(for example, miR-27a, see Figure 4 and Table 1), and making
it impossible to accurately normalize the array data for naïve
T cells relative to the signal obtained from other cell types.
Discussion
In summary, pairwise comparisons of the expression of 181
mature miRNAs in selected highly purified hematopoietic cell
types at immature, mature, and effector stages revealed spe-
cific differences between related cell types (see also Addi-
tional Data Files 1, 2, 3). As described above, the differences
were confirmed by Northern analyses (Figures 2, 3 and 4, and
Tables 1 and 2) and revealed a subset of miRNAs expressed at
Analysis of microarray dataFigure 5
Analysis of microarray data. (a) Heat map of miRNAs expressed at least three times over the background for at least one of the samples. (b) Hierarchical 
clustering of hematopoietic samples (see analysis in Table 3). DN T, double-negative thymocyte; MEF, mouse embryo fibroblast.
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nhigher levels in the hematopoietic system compared with
neuronal tissue (Figure 5a). Figure 6 shows a schematic
hematopoietic lineage tree, where lymphoid and myeloid cells
derive from a common lymphoid and common myeloid pro-
genitor, respectively. Both these cell types derive from a com-
mon precursor further upstream in the differentiation
process and we used the Pu.1-/- cells as a model for such pre-
cursors. The figure also shows a summary of some confirmed
changes in miRNA expression in the different stages of cell
differentiation superimposed on the diagram, showing pre-
cursor-progeny relationships in lymphocyte and mast cell dif-
ferentiation. Even though only selected hematopoietic cell
lineages were analyzed, each differentiation step was
characterized by changes in miRNA expression, with some
miRNAs showing increased and some showing decreased
expression. MiR-150 expression is of particular interest: this
miRNA is up-regulated during the developmental stages of B
and T cell maturation, but down-regulated again during the
further differentiation of naïve T cells into effector Th1 and
Th2 cells. miR-146 is also notable, since it is upregulated in
Th1, but not Th2 cells. We therefore predict that these miR-
NAs probably play a role in establishing and/or maintaining
cell identity in lymphocytes.
Differentiation of naïve T cells into Th1 and Th2 effector cells
is a particularly tractable system for studying cell lineage
specification. Northern blot analyses indicated that several
miRNAs are rapidly down-regulated following activation of
naïve T cells under both Th1 and Th2 differentiation condi-
tions. miR-146 was a clear exception to this pattern, being up-
regulated in Th1, but not Th2 cells. In this respect, miR-146
joins a group of Th1-associated genes that include cytokines
(Ifnγ, Tnfα), chemokine receptors (Cxcr3, Ccr5), and tran-
scription factors (Tbx21, Hlx) [6,24,25]. Our results suggest
two hypotheses for further testing. Firstly, the transcription
of pri-miRNAs may be controlled by the same transcription
factors known to control specific cell differentiation events.
For example, T-bet directs Ifnγ expression, and may also acti-
vate transcription of pri-miR-146. Conversely, miRNAs that
are regulated during cell differentiation may target one or
more of the mRNAs known to be differentially expressed
between Th1 and Th2 cells. Although the predicted targets of
conserved miRNAs represent a diverse array of gene products
[26-30], targeting of key transcription factors would repre-
sent a particularly efficient means for miRNA participation in
cell fate decisions.
Our results call to attention the 'common logic' and shared
roles of transcriptional regulation by transcription factors
and post-transcriptional regulation by miRNAs [5]. It is likely
that both pathways of regulation are integral to successful
regulation of hematopoietic cell differentiation. Decades of
research have been devoted to the elucidation of the tran-
scriptional networks involved in hematopoiesis. For example,
the Ets family transcription factor, PU.1, is necessary for the
generation of certain hematopoietic lineages but not others: it
directs the differentiation of hematopoietic progenitors into
macrophages, neutrophils, B lymphocytes and mast cells, but
is not involved in erythroid or megakaryocytic differentiation
[21,22]. Lineage specification is controlled by the level of PU.1
expression and by which partner transcription factors are co-
expressed: for instance, low levels of PU.1 and co-expression
of early B-cell factor (EBF) control differentiation to the B cell
lineage, whereas high levels of PU.1 predispose to macro-
phage differentiation unless GATA2 is co-expressed, in which
case differentiation is tilted to the mast cell lineage
[22,31,32]. It will be informative to compare miRNA expres-
sion in Pu.1-/- progenitor cells that have been reconstituted
to promote differentiation along these various lineages. Fur-
ther study of the expression and function of miRNAs in
hematopoiesis will probably uncover additional complexity
and subtlety, as well as interconnections between miRNA and
transcription factor networks [5].
Systematic analysis of miRNA expression patterns within our
dataset indicates that besides influencing the process of com-
Table 3
Correlation coefficients (Pearson correlation)
Naïve DN T Pro-B Pu.1-/- Spleen B BMMC Th1 Th2
Naïve 1.00
DN T 0.50 1.00
Pro-B 0.47 0.94 1.00
Pu.1-/- 0.56 0.83 0.78 1.00
Spleen B 0.76 0.87 0.80 0.81 1.00
BMMC 0.63 0.74 0.68 0.78 0.79 1.00
Th1 0.68 0.85 0.79 0.84 0.88 0.92 1.00
Th2 0.67 0.83 0.80 0.84 0.87 0.90 0.96 1.00
The table represents a standard statistical correlation between the indicated samples, where 1 = perfectly correlated and 0 = uncorrelated. BMMC, 
bone marrow-derived mast cell; DN T, double-negative thymocyte.Genome Biology 2005, 6:R71
R71.12 Genome Biology 2005,     Volume 6, Issue 8, Article R71       Monticelli et al. http://genomebiology.com/2005/6/8/R71mitment to a particular cellular lineage, miRNAs may play an
important general role in the mechanism of cell differentia-
tion and maintenance of cell identity. The highest degree of
correlation in the expression pattern of miRNAs was
observed 'horizontally' between hematopoietic cell types at a
similar stage of differentiation. For instance, early B and T
cell precursors are more closely related to each other in their
miRNA expression patterns than to their more differentiated
progeny, mature splenic B cells and naïve T cells. Most strik-
ingly, fully differentiated effector cells, including the closely
related Th1 and Th2 cells, but also the much more distantly
related BMMC, are more closely related to each other in their
miRNA expression pattern than to their respective precursor
cells. The high degree of correlation in the miRNA expression
patterns of these distantly related immune effectors suggests
that a common set of miRNAs may be employed in both line-
ages to regulate similar effector functions, such as tissue
homing and cytokine production. Alternatively, these find-
ings may reflect a general role for some of these miRNAs in
stabilizing gene expression and thereby lineage specification.
This could be accomplished through the promiscuous target-
ing of many transcripts or by specific targeting of genes that
regulate the plasticity of transcriptional states, such as chro-
matin-modifying proteins. Similarly, miRNAs shared among
early precursors may regulate precursor cell self-renewal and
maintenance of an undifferentiated state. The rapid loss of
several miRNAs early in the process of differentiation of Th1
and Th2 effector cells from naïve T cell precursors is consist-
ent with this concept.
Conclusion
We report miRNA expression patterns for diverse murine
hematopoietic cells types, identify a subset of miRNAs prefer-
MiRNA expression and lineage commitmentFigure 6
MiRNA expression and lineage commitment. Expression of miRNA in the hematopoietic system changes depending on the differentiation status. Part of 
the hematopoietic differentiation tree is represented: myeloid and lymphoid progenitors derive from a common progenitor, which is represented by the 
model Pu.1-/- cell line (see text). The common lymphoid progenitor gives rise to B and T lymphocytes and the common myeloid progenitor gives rise to 
mast cells and other cells types. Superimposed on this diagram are examples of miRNAs that were discovered to be differentially expressed between the 
indicated precursor/progeny pairs using array analysis with confirmation by Northern blot. DN, double-negative.
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nentially expressed in the hematopoietic system compared
with neuronal cells, and identify individual miRNA
expression changes that occur during cell differentiation. Our
data support the use of the miRNA microarray for detection
of patterns of miRNA expression and for quantification of
miRNA expression, with the obvious advantage that the
expression of several hundred genes can be identified in the
same sample at once, and with relatively small amounts of
total RNA. Deciphering the miRNA expression status of cells
under different conditions of development and activation and
in different disease states will be useful to identify miRNA
targets, and alterations in the pattern of miRNA expression
may disclose new pathogenic pathways and new ways to tar-
get diseases.
Materials and methods
Tissue preparation, cells differentiation and RNA 
extraction
Hippocampi were dissected from 10-14 week old Balb/c mice.
For pro-B cell preparation, bone marrow cells were isolated
from femurs and tibias of 6-12 week old Rag2-/- C57BL/6 ×
129 mice and pro-B cells were isolated using CD19 MACS
beads. Spleen B cells were isolated using CD19 MACS beads
from splenocytes obtained from 6-12 week old C57BL/6 mice.
Double-negative thymocytes (DN T) were obtained from the
thymi of 4-6 week old Rag2-/- C57BL/6 × 129 mice without
purification; more than 90% of the cells were DN2 and DN3
(not shown). Due to the low amount of cells that can be
obtained from one mouse, proB and DN T cells were purified
from 20 Rag-/- mice, while the spleen B cells were obtained
from 10 C57BL/6 mice, and the samples were pooled.
BMMC preparation and differentiation was as previously
described [33,34]. Briefly, bone marrow cells were isolated
from femurs and tibias of 6-12 week old BALB/c mice and
maintained for 4-12 weeks in RPMI medium containing 50%
WEHI-3 (American Type Culture Collection, VA, USA) condi-
tioned supernatant as a source of IL-3.
Pu.1 knock-out cells were kindly provided by Dr Harinder
Singh (University of Chicago), and were maintained in IMDM
media supplemented with 10 ng/ml of recombinant IL-3
(Peprotech Inc., NJ, USA). Naïve CD4 cells were purified
from spleen and lymph nodes of Tcrα-/- DO11 TCR trans-
genic mice by magnetic bead selection (Dynal, Oslo, Norway)
as previously described [33]. Primary Th1 and Th2 cells were
differentiated in culture for 7 days as previously described
[35]. Murine Th1 (D5) and Th2 (D10) clones were maintained
as previously described [36]. RNA was prepared using
Ultraspec or Trizol reagents following manufacturer's
instructions.
Oligonucleotide array for miRNA
This method has been previously described (see [20]). Briefly,
trimer oligonucleotides (antisense to miRNAs) of 54-72
nucleotides at a final concentration of 7 µM were spotted on
GeneScreen Plus (NEN) membranes with a 1536 pin plate
replicator (V&P Scientific, CA, USA). Oligonucleotides were
immobilized in 100 mM NaOH, after which the membranes
were briefly neutralized in 5% SDS at room temperature and
with 0.2% SDS at 72°C. Arrays were stored in 0.2% SDS at -
4°C.
Total RNA (5-10 µg) from hippocampus tissue and various
hematopoietic cell types was preheated at 80°C for 3 min,
cooled on ice and filtered through Microcon YM-100 concen-
trators to obtain a low molecular weight (LMW) fraction of
RNA enriched in molecules less than 60 nucleotides in size.
The LMW RNA was end-labeled with 30 µCi of γ33P dATP
(3000 Ci/mmole) with T4 polynucleotide kinase, and
purified using the QIAgen Nucleotide Removal kit (QIAgen
Inc., CA, USA).
For hybridization, membranes were first prehybridized in
MicroHyb hybridization buffer (ResGen, AL, USA) at 37°C for
at least 30 min, followed by an overnight hybridization in the
same solution containing the RNA probe. Following
hybridization, membranes were washed twice in 2 × SSC/
0.5% SDS at 37°C and once in 1 × SSC/0.5% SDS at 37°C.
Membranes were exposed to a phosphor storage screen,
scanned using a Phosphor Imager, and signals were quanti-
fied using the ImageQuant software (Molecular Dynamics,
CA, USA). For reuse, membranes were stripped with 0.2%
SDS at 72°C, tested again by exposure to phosphorimager
screen, and rehybridized three to five times. Each experiment
included two to three independent RNA samples and to
ensure accuracy of the hybridizations, each RNA sample was
hybridized with three membranes.
To confirm specificity, a series of oligonucleotides with three
mismatches (G>C or C>A) were included on the array. These
mismatches resulted in a significant drop in signal intensity
as compared with their cognates. The melting temperature of
oligo probe:miRNA pairs could affect the sensitivity and spe-
cificity of the arrays for different miRNAs. An analysis of this
correlation showed that hybridization signals significantly
above background were obtained for probes in a wide range of
melting temperatures (Additional Data File 4). Also, three
synthetic 21-nt RNA oligonucleotides with sequences that do
not correspond to any known miRNA, but that are exact com-
plements to randomly spotted sequences, were added to the
RNA samples at a known concentration as a reference for
normalization.
Northern blot analysis
Total RNA (20 µg) was loaded and separated on a denaturing
12-15% polyacrylamide gel and transferred electrophoreti-
cally to a GeneScreen Plus or Nytran SuPerCharge membrane
(Scheicher and Schuell, NH, USA). Membranes were UV-
crosslinked. Probes were prepared by T4 polynucleotide
kinase labeling of antisense oligonucleotides with γ32P dATP.Genome Biology 2005, 6:R71
R71.14 Genome Biology 2005,     Volume 6, Issue 8, Article R71       Monticelli et al. http://genomebiology.com/2005/6/8/R71Hybridization was performed with UltraHyb Hybridization
buffer (Ambion, TX, USA) or Denhardt's solution at 37-42°C.
Blots were washed at the same temperature with 2 × SSC/
0.1% SDS with a brief final wash with 0.1 × SSC/0.1% SDS.
Radiolabeled Decade RNA markers (Ambion) were loaded as
size markers. tRNA and 5S RNA stained with ethidium bro-
mide served as a sample loading control. For reuse, blots were
stripped by boiling in 0.1 × SSC/0.1% SDS twice for 10 min
and reprobed.
Data analysis
Before analysis, the raw data needed to be processed in order
to handle overall scaling differences between the individual
scans and negative values arising from the background sub-
traction. Although these are common issues in array-based
experiments, it is not obvious what the optimal preprocessing
algorithm should be. For the data presented here, the Vari-
ance Stabilization Normalization method [37] was used. The
method has a considerable advantage in that it uses a gener-
alized log transformation that can deal directly with negative
values, eliminating the need to artificially shift or truncate
these data points.
Standard hierarchical clustering with average linkage was
used to cluster the hematopoietic samples. A subset of the
miRNAs was used to compute the distance function. These
miRNAs had to have a signal level of three times the back-
ground standard deviation in at least one of the hematopoi-
etic samples. The Pearson correlation was used to compute
the distance function with dist = (1-ρ)/2 where ρ is the corre-
lation. To assess the robustness of the results, bootstrap resa-
mpling was carried out using a parametric method to add
noise to the data. Gaussian noise with zero mean and a stand-
ard deviation equal to that for each spot's replicates was
added to each point. One thousand resampled datasets were
created and clustered with a consensus tree built from the
results. The number at each node indicates how often that
subtree appeared in the 1000 replica trees.
To identify miRNAs that were differentially expressed
between the various sample subtypes, a variation of the
standard t-test was used on the transformed expression val-
ues. To handle the low number of samples, a Bayesian correc-
tion method [38] was used to adjust the standard deviation.
To account for the multiple testing problem, the False Discov-
ery Rate (FDR) method was used and the lists were cut off at
specific values of the FDR. Additionally, the results were fil-
tered to include only those miRNAs that were expressed
threefold above the background standard deviation in at least
one sample.
Data availability
The primary microarray data is deposited in the ArrayExpress
database with accession number E-MEXP-372.
Additional data files
The following additional data are available with the online
version of this article: miRNAs differentially expressed
between hippocampus and combined hematopoietic samples
(Additional data file 1), miRNAs differentially expressed
between BMMC and Th1, Th2 and Pu.1-/- cells (Additional
data file 2), miRNAs differentially expressed between spleen
B versus pro-B (Additional data file 3), and an analysis of the
probe melting temperatures (Tm) versus the average signal
obtained in the arrays (Additional data file 4).
Additional data file 1miRNAs differentially expressed between hippocampus and com-bined hematopoietic sampl .For normalizati n the VSN method was used [37]. A standard t-test on the gener lized log transforme  express on level  was used o ra k t iRNAs and comput  p valu s. T e results ere filtered to iscar  ny m RNA who e signal a  ot thr e ime bov he c grou d in at ast one of he two groups and whos oluf l  ch ng  was l ss tha  3.Cl c  e e for f l 2M  t  BMMC nd Th1, Th2 andPu.1-/- c s.T handl th  l w mple n mbers, the Bay sian corr ct d t-test [38] w used  r k nd c pu e p valu s. Th  differ nt compar-is n ad gr tly v r ing significances, so iffer n cut offs w  used n c  list. Fo  he BMMC v rsu  Th1 a d Th2 comparis ,a FDR c to of 10-2 was u ed, with a filt r of t ee ti s b ckground lev ls nd  fold cha g  f thr F r BMMC versus omp rison a FDR  10-6 nd fo  t m  backgr un  filterwas us d. 3 ple  v us p o B.he FDR cu f 10-6 a kg o nd filt r was fo  im s.4aly i f the p obe m lting temper t re ( m) ve s  he av rg sig al bt d in h arrays.re is  le c rr l io be e Tm an st ng h f ign l fl pr b use  ( f  p l). T i true if nly th  pr br miRNA th r nti i d as 'high i op ie ic c l s' (g r  5 ) c s d r d (ri ht l). Al ,  l e  p  h vm that sp  lm st e tire r ng of m e n for a l the probv n v rage Tm (56°C) ly slightly igh  tha he av r-of h p b (54°C)  Th  m an t a ov rall, the f h se iff r n g s  ro s i  t ray is i   v li , vwe m y h v o t s of h low m miRNA fa e n gt ve s , nd me f th h Tm bes ay hav gi e wp i iv  sig .
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